Central administration of peptide and small molecule MC4 receptor antagonists induce hyperphagia in mice and attenuate cytokine-induced anorexia
- 25 March 2005
- Vol. 26 (11) , 2294-2301
- https://doi.org/10.1016/j.peptides.2005.03.002
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Inverse agonism gains weightTrends in Pharmacological Sciences, 2003
- Body Weight Regulation by Selective MC4 Receptor Agonists and AntagonistsAnnals of the New York Academy of Sciences, 2003
- Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor GeneNew England Journal of Medicine, 2003
- Binge Eating as a Major Phenotype of Melanocortin 4 Receptor Gene MutationsNew England Journal of Medicine, 2003
- Selective, High Affinity Peptide Antagonists of α-Melanotropin Action at Human Melanocortin Receptor 4: Their Synthesis and Biological Evaluation in VitroJournal of Medicinal Chemistry, 2001
- Potent and Selective Peptide Agonists of α-Melanotropin Action at Human Melanocortin Receptor 4: Their Synthesis and Biological Evaluation in VitroBiochemical and Biophysical Research Communications, 2001
- Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body massNature Genetics, 2000
- A Unique Metalolic Sysdrone Causes Obesity in the Melanocortin-3 Receptor-Deficient MouseEndocrinology, 2000
- Central injection in rats of α-melanocyte-stimulating hormone analog: effects on food intake and brain FosRegulatory Peptides, 1998
- Feeding effects of hypothalamic injection of melanocortin 4 receptor ligandsBrain Research, 1998